Quest Diagnostics Inc

Ownership Transactions Reported by 23 Insiders

Symbol
DGX on NYSE
Industry
Services-Medical Laboratories
Location
500 Plaza Drive, Secaucus, New Jersey

Insiders trading volume in the past year

Quest Diagnostics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Stephen H. Rusckowski Director $47.9M Mar 6, 2023
E. Davis CEO and President, Director $24M Feb 28, 2024
Mark Guinan Executive Vice President & CFO $13.1M Mar 7, 2022
Catherine T. Doherty EVP, Regional Businesses $10.7M -$956K -8.2% Feb 28, 2024
Manner Carrie Eglinton SVP, Advanced Diagnostics $7.59M Mar 7, 2022
Michael E. Prevoznik SVP & General Counsel $6.83M -$5.83M -46.1% Aug 29, 2024
Timothy M. Ring Director $6.04M Jul 1, 2024
Michael J. Deppe SVP, Corp. Controller & CAO $4.7M Feb 28, 2024
Sam Samad Executive Vice President & CFO $4.55M Jul 22, 2024
Gail R. Wilensky Director $4.16M May 17, 2023
Gary M. Pfeiffer Director $4.05M May 16, 2024
Timothy L. Main Director $3.51M May 16, 2024
Patrick Plewman SVP for Diagnostic Services $3.26M Jul 22, 2024
Karthik Kuppusamy SVP, Clinical Solutions $3M -$551K -15.5% Aug 28, 2024
Vicky B. Gregg Director $2.64M -$317K -10.7% Jul 22, 2024
Mark E. Delaney SVP & Chief Commercial Officer $1.57M -$60.1K -3.7% Jul 24, 2024
Mark A. Gardner SVP of Molecular Gen & Oncol $1.42M Feb 28, 2024
Denise M. Morrison Director $1.33M May 16, 2024
Wright Lassiter III Director $1.08M May 16, 2024
Helen Torley Director $769K May 25, 2021
Tracey Doi Director $726K May 16, 2024
Luis Diaz Director $399K May 16, 2024
Robert B. Carter Director $207K May 16, 2024

Recent Insider Transactions by Companies or Individuals for Quest Diagnostics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.